Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek’s disease virus strains, RB1B and Md5
Authors:
- 19 April 2011
- journal article
- Published by Springer Nature in Virus Genes
- Vol. 43 (1) , 66-71
Abstract
Marek’s disease virus (MDV) is an oncogenic herpesvirus that causes malignant lymphomas in chickens. Recent field isolates of MDV have tended to exhibit increasing virulence, and MDV strains are currently classified into four categories based on their relative virulence. Meq, a putative MDV oncoprotein, resembles the Jun/Fos family of basic leucine zipper (bZIP) transcription factors and can regulate the expression of viral and cellular genes as a homodimer or as a heterodimer with a variety of bZIP family proteins. MDV isolates display distinct diversity and point mutations in Meq, which may contribute to changes in the transcriptional activities of Meq and subsequently, to observed increases in MDV oncogenicity. In this study, we introduced mutations into the meq gene and used dual luciferase reporter assays to analyze the transcriptional activities of the resulting Meq proteins to determine whether distinct mutations in Meq could be responsible for differences in transcriptional activity among MDV strains. A proline-to-alanine substitution at position 217, the second position of one of the proline direct repeats in the transactivation domain, enhanced the transactivation activity of Meq. In addition, we found that two substitutions at positions 283 and 320 affected transactivation activity. These results suggest that the distinct diversity of and point mutations in the Meq proteins are responsible for differences in transactivation activity among MDV strains.Keywords
This publication has 25 references indexed in Scilit:
- In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988Virus Research, 2009
- Identification and characterization of a novel spliced form of the meq transcript in lymphoblastoid cell lines derived from Marek's disease tumoursJournal of General Virology, 2007
- Comparative analysis of Marek’s disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulenceVeterinary Microbiology, 2004
- Characterization of the Chromosomal Binding Sites andDimerization Partners of the Viral Oncoprotein Meq in Marek'sDisease Virus-Transformed TCellsJournal of Virology, 2003
- Difference in the meq Gene between Oncogenic and Attenuated Strains of Marek's Disease Virus Serotype 1.Journal of Veterinary Medical Science, 2000
- Isolation and Characterization of Marek's Disease Virus (MDV) cDNAs Mapping to theBamHI-I2,BamHI-Q2, andBamHI-L Fragments of the MDV Genome from Lymphoblastoid Cells Transformed and Persistently Infected with MDVVirology, 1995
- Further characterization of marek's disease virus‐infected lymphocytes. I. In vivo infectionInternational Journal of Cancer, 1984
- Further characterization of marek's disease virus‐infected lymphocytes. II. In vitro infectionInternational Journal of Cancer, 1984
- Characterisation of two highly oncogenic strains of Marek's disease virus12Avian Pathology, 1982
- Pathogenicity of Variant Marek's Disease Virus Isolants in Vaccinated and Unvaccinated ChickensAvian Diseases, 1980